InVivoSIM anti-human CD19 (Loncastuximab Biosimilar)

货号 #SIM0075
克隆号:
Loncastuximab

¥2,527 - ¥87,620

选择参数
  • 100 mg - ¥87,620
  • 50 mg - ¥49,234
  • 25 mg - ¥34,252
  • 5 mg - ¥9,807
  • 1 mg - ¥2,527
  • 定制包装(请询价)

产品详情

This non-therapeutic biosimilar antibody uses the same variable regions as the therapeutic antibody, loncastuximab, making it ideal for research use. Loncastuximab is a humanized IgG1, k monoclonal antibody that reacts with the human B-cell marker CD19, a membrane glycoprotein of the immunoglobulin superfamily that is expressed at the various stages of B-cell development and is detectable in most B-cell malignancies. CD19 is an ideal target for antibody-drug conjugates (ADCs) and other therapies because it plays a key role in lymphocyte biology, is uniquely expressed on B cells, and is rapidly internalized without shedding into the bloodstream. These properties make it especially valuable in research on B cells and relapsed or refractory diffuse large B-cell lymphoma (DLBCL), the most common form of non-Hodgkin lymphoma. Loncastuximab tesirine is a human CD19-directed ADC, wherein the antibody is conjugated through a cathepsin-cleavable linker to SG3199, a potent pyrrolobenzodiazepine dimer alkylating cytotoxin. Upon binding to CD19 on the cell membrane, the ADC is internalized and transported to lysosomes, where it is cleaved to release the drug inside the cells, ultimately inducing apoptotic cell death through the crosslinking of DNA. In vitro experiments using loncastuximab tesirine in multiple lymphoma cell lines demonstrated this ADC’s strong cytotoxic activity that correlated with the level of CD19 expression. The in vivo treatment of loncastuximab tesirine is also reported to show dose-dependent antitumor activity in human CD19-expressing Burkitt lymphoma-derived Ramos models (subcutaneous as well as disseminated xenograft models involving Ramos and NALM-6 cells).

参数

同种型 Human IgG1, κ
推荐的同型对照 RecombiMAb human IgG1 isotype control, anti-hen egg lysozyme
推荐稀释缓冲液 InVivoPure pH 6.0T Dilution Buffer
免疫原 Human CD19
Reported Applications Antibody-drug conjugate synthesis In vivo functional assays in vitro functional assays Flow cytometry ELISA
形式 PBS, pH 6.0 Contains no stabilizers or preservatives
内毒素 ≤0.5EU/mg (≤0.0005EU/μg) Determined by LAL assay
聚合 <5% Determined by SEC
纯化 ≥95% Determined by SDS-PAGE
无菌性 0.2 μM filtration
生产 Purified from cell culture supernatant in an animal-free facility
提纯 Protein A
分子量 150 kDa
小鼠病原体试验 Mouse Norovirus: Negative Mouse Parvovirus: Negative Mouse Minute Virus: Negative Mouse Hepatitis Virus: Negative Reovirus Screen: Negative Lymphocytic Choriomeningitis virus: Negative Lactate Dehydrogenase-Elevating Virus: Negative Mouse Rotavirus: Negative Theiler's Murine Encephalomyelitis: Negative Ectromelia/Mousepox Virus: Negative Hantavirus: Negative Polyoma Virus: Negative Mouse Adenovirus: Negative Sendai Virus: Negative Mycoplasma Pulmonis: Negative Pneumonia Virus of Mice: Negative Mouse Cytomegalovirus: Negative K Virus: Negative
保存 The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
点击关闭